Paul B. Keiser

2.2k total citations · 1 hit paper
35 papers, 1.6k citations indexed

About

Paul B. Keiser is a scholar working on Infectious Diseases, Microbiology and Epidemiology. According to data from OpenAlex, Paul B. Keiser has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Microbiology and 11 papers in Epidemiology. Recurrent topics in Paul B. Keiser's work include Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (9 papers) and Parasites and Host Interactions (7 papers). Paul B. Keiser is often cited by papers focused on Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (9 papers) and Parasites and Host Interactions (7 papers). Paul B. Keiser collaborates with scholars based in United States, Mali and Belgium. Paul B. Keiser's co-authors include Thomas B. Nutman, Wendell D. Zollinger, Valerian B. Pinto, Theodore E. Nash, Deborah H. Schmiel, Mark B. Stoddard, Elizabeth Morán, Elaine Thomas, Christopher Ohl and Thomas A. Moore and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Clinical Microbiology Reviews.

In The Last Decade

Paul B. Keiser

35 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Strongyloides stercoralisin the Immunocompromised Population

2004 640 citations Paul B. Keiser, Thomas B. Nutman profile →

Peers

Countries citing papers authored by Paul B. Keiser

Since Specialization

Citations

This map shows the geographic impact of Paul B. Keiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Keiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Keiser more than expected).

Fields of papers citing papers by Paul B. Keiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul B. Keiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Keiser. The network helps show where Paul B. Keiser may publish in the future.

Co-authorship network of co-authors of Paul B. Keiser

This figure shows the co-authorship network connecting the top 25 collaborators of Paul B. Keiser. A scholar is included among the top collaborators of Paul B. Keiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul B. Keiser. Paul B. Keiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection 2024 ·npj Vaccines ·Jay W. Hooper, Steven A. Kwilas, Matthew Josleyn, Sarah L. Norris, Jack Hutter, (unknown), Jeffrey Livezey, Kristopher Paolino, Patrick Twomey, Michael Koren, Paul B. Keiser, James E. Moon, (unknown), Jason I. Koontz, (unknown), Nathalie Landry, (unknown)	4
2	Canine caliciviruses of four serotypes from military and research dogs recovered in 1963−1978 belong to two phylogenetic clades in the Vesivirus genus 2018 ·Virology Journal ·Leonard N. Binn, (unknown), Ruth H. Marchwicki, (unknown), Paul B. Keiser, Jun Hang	6
3	Composition and variation of respiratory microbiota in healthy military personnel 2017 ·PLoS ONE ·Jun Hang, Nela Zavaljevski, Yu Yang, Valmik Desai, Richard C. Ruck, Louis Macareo, Richard G. Jarman, Jaques Reifman, Robert A. Kuschner, Paul B. Keiser	18
4	Adenovirus type 4 respiratory infections with a concurrent outbreak of coxsackievirus A21 among United States Army Basic Trainees, a retrospective viral etiology study using next‐generation sequencing 2017 ·Journal of Medical Virology ·Jun Hang, Todd J. Vento, (unknown), Richard G. Jarman, Paul B. Keiser, Robert A. Kuschner, Leonard N. Binn	19
5	Should U.S. Troops Routinely Get Rabies Pre-Exposure Prophylaxis? 2014 ·Military Medicine ·(unknown), Paul B. Keiser	2
6	Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response 2012 ·Human Vaccines & Immunotherapeutics ·Paul B. Keiser, Michael P. Broderick	8
7	A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression 2011 ·Vaccine ·Paul B. Keiser, (unknown), Elizabeth Morán, Deborah H. Schmiel, Valerian B. Pinto, (unknown), (unknown), James E. Moon, Robert A. Bowden, James F. Cummings, Wendell D. Zollinger	118
8	Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine 2011 ·Vaccine ·Mark S. Riddle, Robert W. Kaminski, (unknown), Chad K. Porter, Shahida Baqar, (unknown), Theron Gilliland, (unknown), (unknown), (unknown), (unknown), (unknown), Paul B. Keiser, Ryan T. Ranallo, Robert Gormley, (unknown), K. Ross Turbyfill, David R. Tribble, Edwin V. Oaks	61
9	A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA 2010 ·Vaccine ·Paul B. Keiser, (unknown), Trinka S. Coster, (unknown), Mark B. Stoddard, Joseph E. Labrie, Deborah H. Schmiel, Valerian B. Pinto, Ping Chen, Wendell D. Zollinger	55
10	Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine 2010 ·Vaccine ·Wendell D. Zollinger, M. A. Donets, Deborah H. Schmiel, Valerian B. Pinto, Joseph E. Labrie, Elizabeth Morán, Brenda L. Brandt, Б. И. Ионин, (unknown), Max T. Wu, Ping Chen, Mark B. Stoddard, Paul B. Keiser	62
11	The majority of US combat casualty soft-tissue wounds are not infected or colonized upon arrival or during treatment at a continental US military medical facility 2010 ·The American Journal of Surgery ·Forest R. Sheppard, Paul B. Keiser, David W. Craft, Fred Gage, Martin C. Robson, Trevor S. Brown, Kyle Petersen, (unknown), (unknown), Jason Hawksworth, Doug Tadaki, Thomas A. Davis, Alexander Stojadinovic, Eric A. Elster	58
12	Whole cell vaccination for meningococcus: Lessons from an idea whose time has gone 2010 ·Human Vaccines ·Joseph E. Labrie, Paul B. Keiser	4
13	Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis 2009 ·Vaccine ·Paul B. Keiser, (unknown), (unknown), Wendell D. Zollinger	5
14	Molecular identification of Wolbachia from the filarial nematode Mansonella perstans 2008 ·Molecular and Biochemical Parasitology ·Paul B. Keiser, Yaya Ibrahim Coulibaly, Joseph Kubofcik, Abdallah A. Diallo, Amy D. Klion, Sékou F. Traorè, Thomas B. Nutman	47
15	Filaria-Induced Monocyte Dysfunction and Its Reversal following Treatment 2006 ·Infection and Immunity ·Roshanak Tolouei Semnani, Paul B. Keiser, Yaya Ibrahim Coulibaly, (unknown), Abdallah A. Diallo, Diakaridia Traoré, Dapa A. Diallo, Ogobara K. Doumbo, Sékou F. Traorè, Joseph Kubofcik, Amy D. Klion, Thomas B. Nutman	44
16	Human Immunoglobulin G Mediates Protective Immunity and Identifies Protective Antigens against LarvalStrongyloides stercoralisin Mice 2004 ·The Journal of Infectious Diseases ·Laura A. Kerepesi, Thomas J. Nolan, Gerhard A. Schad, Sara Lustigman, De’Broski R. Herbert, Paul B. Keiser, Thomas B. Nutman, Alejandro Krolewiecki, David Abraham	30
17	Prolonged Perilesional Edema after Treatment of Parenchymal Neurocysticercosis: Methotrexate as a Corticosteroid‐Sparing Agent 2003 ·Clinical Infectious Diseases ·Paul B. Keiser, Theodore E. Nash	14
18	CLINICAL CHARACTERISTICS OF POST-TREATMENT REACTIONS TO IVERMECTIN/ALBENDAZOLE FOR WUCHERERIA BANCROFTI IN A REGION CO-ENDEMIC FOR MANSONELLA PERSTANS 2003 ·American Journal of Tropical Medicine and Hygiene ·Paul B. Keiser, Yaya Ibrahim Coulibaly, (unknown), Diakaridia Traoré, Abdallah A. Diallo, Dapa A. Diallo, Roshanak Tolouei Semnani, Ogobara K. Doumbo, Sékou F. Traorè, Amy D. Klion, Thomas B. Nutman	22
19	Update on lymphatic filarial infections 2002 ·Current Infectious Disease Reports ·Paul B. Keiser, Thomas B. Nutman	13
20	Treatment of Patients with Refractory Giardiasis 2001 ·Clinical Infectious Diseases ·Theodore E. Nash, Christopher Ohl, Elaine Thomas, (unknown), Paul B. Keiser, Thomas A. Moore	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact